A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors
暂无分享,去创建一个
Thorsten Heinzel | C. Glass | M. Rosenfeld | Sheng-Cai Lin | B. Gloss | Lan Xu | D. Rose | J. Torchia | Y. Kamei | R. Kurokawa | T. Heinzel | R. Heyman | Sheng-Cai Lin | Christopher K Glass | Michael G Rosenfeld | David W Rose | Lan Xu | Joseph Torchia | Riki Kurokawa | Bernd Gloss | Richard A Heyman | Yasutomi Kamei | Yasutomi Kamei
[1] Michael R. Green,et al. Nuclear protein CBP is a coactivator for the transcription factor CREB , 1994, Nature.
[2] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[3] P. Kushner,et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.
[4] Myles Brown,et al. Polarity-specific activities of retinoic acid receptors determined by a co-repressor , 1995, Nature.
[5] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[6] Peggy J. Farnham,et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.
[7] D. Livingston,et al. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein , 1995, Nature.
[8] Roger Brent,et al. C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .
[9] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[10] M. Karin,et al. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor , 1994, Nature.
[11] S. McKnight,et al. In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. , 1988, Genes & development.
[12] D. Reinberg,et al. Regulation of RNA polymerase II transcription. , 1993, Current opinion in cell biology.
[13] R. Tjian,et al. TAFs and TFIIA mediate differential utilization of the tandem Adh promoters , 1995, Cell.
[14] S. Narumiya,et al. Alteration of a single amino acid residue in retinoic acid receptor causes dominant-negative phenotype. , 1994, The Journal of biological chemistry.
[15] L. Swanson,et al. TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. , 1991, Genes & development.
[16] D. Moore,et al. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.
[17] K. Umesono,et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.
[18] R. Goodman,et al. Adenoviral ElA-associated protein p300 as a functional homologue of the transcriptional co-activator CBP , 1995, Nature.
[19] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[20] E. Appella,et al. H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. , 1992, The EMBO journal.
[21] P. Chambon,et al. The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.
[22] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[23] B. O’Malley,et al. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.
[24] J B Lawrence,et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.
[25] A. Fanjul,et al. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. , 1993, Molecular endocrinology.
[26] F. C. Lucibello,et al. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. , 1990, The EMBO journal.
[27] M. Montminy,et al. Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressers , 1993, Nature.
[28] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[29] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[30] B. O’Malley,et al. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.
[31] M. Pfahl,et al. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.
[32] T. Bugge,et al. RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. , 1992, The EMBO journal.
[33] M. Karin,et al. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.
[34] M. Parker,et al. Interaction of proteins with transcriptionally active estrogen receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Baulieu,et al. Steroid hormone receptors. , 1975, Vitamins and hormones.
[36] W. Sellers,et al. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators , 1994, Cell.
[37] O. Hankinson. The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.
[38] K. Umesono,et al. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Karin,et al. Negative transcriptional regulation by nuclear receptors. , 1994, Seminars in cancer biology.
[40] B. O’Malley,et al. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing , 1995, Molecular and cellular biology.
[41] P. Herrlich,et al. Interference between pathway‐specific transcription factors: glucocorticoids antagonize phorbol ester‐induced AP‐1 activity without altering AP‐1 site occupation in vivo. , 1992, The EMBO journal.
[42] M. Rosenfeld,et al. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth , 1992, Nature.
[43] F. Winston,et al. Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. , 1992, Trends in genetics : TIG.
[44] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[45] B. Gloss,et al. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element , 1990, Journal of virology.
[46] C. Glass,et al. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.
[47] M. Pfahl,et al. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. , 1991, Molecular endocrinology.
[48] Andrew J. Bannister,et al. CBP‐induced stimulation of c‐Fos activity is abrogated by E1A. , 1995, The EMBO journal.
[49] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[50] I. Herskowitz,et al. Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription , 1992, Cell.
[51] Masatoshi Hagiwara,et al. Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.
[52] G. Martin,et al. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.
[53] Jeffrey A. Lefstin,et al. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. , 1994, Genes & development.
[54] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[55] D. Rose,et al. Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis , 1992, The Journal of cell biology.
[56] M. Montminy,et al. Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB , 1991, Molecular and cellular biology.
[57] Thorsten Heinzel,et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.
[58] Philippe Kastner,et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.
[59] P Chambon,et al. The retinoid signaling pathway: molecular and genetic analyses. , 1994, Seminars in cell biology.
[60] T. Curran,et al. Encounters with Fos and Jun on the road to AP-1. , 1990, Seminars in cancer biology.
[61] J. Samarut,et al. A novel mechanism of action for v-ErbA: Abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors , 1991, Cell.